Craft

Inotiv

Stock Price

$1.7

2024-06-28

Market Capitalization

$43.1 M

2024-06-28

Revenue

$572.4 M

FY, 2023

Inotiv Summary

Company Summary

Overview
Inotiv (formerly known as BioAnalytical Systems) provides research services to pharmaceutical and biotechnology companies. The company focuses on providing drug developers with scientific research and analytical instrumentation. It operates in two segments: the Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing, and Research Products segment focuses on expediting preclinical screening of developmental drugs.
Type
Public
Status
Active
Founded
1974
HQ
West Lafayette, IN, US | view all locations
Website
https://www.inotivco.com/
Cybersecurity rating
Sectors

Key People

  • John Sagartz

    John Sagartz, Chief Strategy Officer and Director

  • Greg Beattie

    Greg Beattie, Chief Operating Officer, DSA

    • Michael A. Baim

      Michael A. Baim, Senior Vice President, Analytical Operations

    • Beth A. Taylor

      Beth A. Taylor, Vice President of Finance and Chief Financial Officer

      LocationsView all

      1 location detected

      • West Lafayette, IN HQ

        United States

        2701 Kent Ave

      Inotiv Financials

      Summary Financials

      Revenue (Q2, 2024)
      $119.0M
      Net income (Q2, 2024)
      ($48.1M)
      Cash (Q2, 2024)
      $32.7M
      EBIT (Q2, 2024)
      ($43.1M)
      Enterprise value
      $389.2M

      Footer menu